Identification of prospective novel drug targets for immune thrombocytopenia by integrating plasma proteome
Objectives The etiology of immune thrombocytopenia (ITP) is heterogeneous and intricate, with some unresponsive to current treatments. We used Mendelian randomization (MR) to identify new therapeutic targets.Methods Genetic instruments for 2923 plasma proteins from the UKBPPP study and ITP data from...
Saved in:
| Main Authors: | Wei He, Jingcheng Zhang, Mingzhe Zhao, Jinyong Fang, Fang He, Caifang Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2545645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteome-wide Mendelian randomization and colocalization analysis identify therapeutic targets for stroke
by: Xueling Zhao, et al.
Published: (2025-07-01) -
Cold environments and health: proteomic analysis of health impacts
by: Song Hongquan, et al.
Published: (2025-04-01) -
Integrative Proteomics and Genomics Identify Novel Biomarkers and Therapeutic Targets in Vitiligo via Mendelian Randomization
by: Chenjue Yan, et al.
Published: (2025-06-01) -
Proteome‐Wide and Immune Cell Phenotype Mendelian Randomization Highlights Immune Involvement in Genetic Generalized Epilepsy
by: Jianxiong Gui, et al.
Published: (2025-06-01) -
Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study
by: Chengjun Li, et al.
Published: (2025-03-01)